133 related articles for article (PubMed ID: 7736317)
1. Acute effects of deflazacort and prednisone on rates of mineralization and bone formation.
Lo Cascio V; Kanis JA; Beneton MN; Bertoldo F; Adami S; Poggi G; Zanolin ME
Calcif Tissue Int; 1995 Feb; 56(2):109-12. PubMed ID: 7736317
[TBL] [Abstract][Full Text] [Related]
2. A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort.
LoCascio V; Ballanti P; Milani S; Bertoldo F; LoCascio C; Zanolin EM; Bonucci E
Calcif Tissue Int; 1998 Mar; 62(3):199-204. PubMed ID: 9501951
[TBL] [Abstract][Full Text] [Related]
3. Effects of prednisone and deflazacort on vertebral bone mass.
Gennari C; Imbimbo B
Calcif Tissue Int; 1985 Dec; 37(6):592-3. PubMed ID: 3937579
[TBL] [Abstract][Full Text] [Related]
4. Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans.
Gennari C; Imbimbo B; Montagnani M; Bernini M; Nardi P; Avioli LV
Calcif Tissue Int; 1984 May; 36(3):245-52. PubMed ID: 6432287
[TBL] [Abstract][Full Text] [Related]
5. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
Cacoub P; Chemlal K; Khalifa P; Wechsler B; De Gennes C; Belmatoug N; Cohen P; Ziza JM; Verdoncq B; Piette JC
J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
[TBL] [Abstract][Full Text] [Related]
6. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
Montecucco C; Caporali R; Caprotti P; Caprotti M; Notario A
J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
[TBL] [Abstract][Full Text] [Related]
7. Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone.
Pagano G; Bruno A; Cavallo-Perin P; Cesco L; Imbimbo B
Arch Intern Med; 1989 May; 149(5):1098-101. PubMed ID: 2655543
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth.
Balsan S; Stéru D; Bourdeau A; Grimberg R; Lenoir G
Calcif Tissue Int; 1987 Jun; 40(6):303-9. PubMed ID: 3111667
[TBL] [Abstract][Full Text] [Related]
9. A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders.
Gray RE; Doherty SM; Galloway J; Coulton L; de Broe M; Kanis JA
Arthritis Rheum; 1991 Mar; 34(3):287-95. PubMed ID: 2003854
[TBL] [Abstract][Full Text] [Related]
10. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis.
Messina OD; Barreira JC; Zanchetta JR; Maldonado-Cocco JA; Bogado CE; Sebastián ON; Flores D; Riopedre AM; Redondo G; Lázaro A
J Rheumatol; 1992 Oct; 19(10):1520-6. PubMed ID: 1464862
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
Loftus J; Allen R; Hesp R; David J; Reid DM; Wright DJ; Green JR; Reeve J; Ansell BM; Woo PM
Pediatrics; 1991 Sep; 88(3):428-36. PubMed ID: 1881719
[TBL] [Abstract][Full Text] [Related]
12. Deflazacort vs prednisone. Effect on blood glucose control in insulin-treated diabetics.
Bruno A; Cavallo-Perin P; Cassader M; Pagano G
Arch Intern Med; 1987 Apr; 147(4):679-80. PubMed ID: 3827456
[TBL] [Abstract][Full Text] [Related]
13. Deflazacort in thrombocytopenia: a comparison with prednisone.
Mazzucconi MG; Malagnino F; De Laurentis C; Criscuolo D
Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):538-42. PubMed ID: 7194867
[TBL] [Abstract][Full Text] [Related]
14. Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: a randomized, double blind study in kidney transplant patients.
Lippuner K; Casez JP; Horber FF; Jaeger P
J Clin Endocrinol Metab; 1998 Nov; 83(11):3795-802. PubMed ID: 9814449
[TBL] [Abstract][Full Text] [Related]
15. Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica.
Lund B; Egsmose C; Jørgensen S; Krogsgaard MR
Calcif Tissue Int; 1987 Dec; 41(6):316-20. PubMed ID: 3124940
[TBL] [Abstract][Full Text] [Related]
16. Deflazacort in the treatment of uveitis: a comparative study versus prednisone.
Cerqueti Piera M; Saccà Sergio C; Allegri P; Ciurlo G; Zingirian M; Buscaglia S; Ciprandi G
Allergol Immunopathol (Madr); 1993; 21(3):107-10. PubMed ID: 8356936
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive effects of deflazacort - a new glucocorticoid with bone-sparing and carbohydrate-sparing properties: comparison with prednisone.
Hahn BH; Pletscher LS; Muniain M
J Rheumatol; 1981; 8(5):783-90. PubMed ID: 6458701
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of glucocorticoids on calcium absorption and bone mass.
Gennari C
Br J Rheumatol; 1993 May; 32 Suppl 2():11-4. PubMed ID: 8495275
[TBL] [Abstract][Full Text] [Related]
20. A randomized study comparing deflazacort and prednisone in heart transplant patients.
Arizón JM; Anguita M; Vallés F; López-Rubio F; López-Granados A; Casares J; Segura J; Mesa D; Muñoz I; Alados P
J Heart Lung Transplant; 1993; 12(5):864-8. PubMed ID: 8241229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
